Home / Market News / $HSTM
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

Canaccord Genuity Maintains HealthStream at Hold, Raises Price Target to $32

Nov 5, 2026, 2:08 PM UTC · Primary ticker $HSTM

Canaccord Genuity maintained its 'Hold' rating on HealthStream but increased its price target from $29 to $32. This adjustment reflects a slightly more optimistic outlook from the analyst firm, though the new target still implies a minor downside from the stock's recent closing price.

Canaccord Genuity reaffirmed its 'Hold' rating on HealthStream, indicating a neutral stance on the stock's near-term performance. However, the firm did raise its price target from $29 to $32, suggesting a slightly improved valuation perspective. This matters to investors as analyst ratings and price targets can influence market sentiment and trading activity, particularly for individual stocks. While the price target increase is positive, the 'Hold' rating and the fact that the new target is slightly below the current market price suggest limited immediate upside. For traders, this presents a moderate signal; it's not a strong buy or sell, but rather an affirmation of current valuation with a minor upward revision.

$HSTM neutral Analyst price target increase
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.